Assignee
FUJISAWA PHARMACEUTICAL CO
JP925 patents
Top patents by PatentIndex Score
US5164372ANov 17, 1992
Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same
FUJISAWA PHARMACEUTICAL CO157 citations99
US5134142AJul 28, 1992
Pyrazole derivatives, and pharmaceutical composition comprising the same
FUJISAWA PHARMACEUTICAL CO284 citations99
US4963530AOct 16, 1990
Renin inhibitor peptide compounds, a process for the preparation thereof and pharmaceutical composition comprising the same
FUJISAWA PHARMACEUTICAL CO167 citations99
US4894366AJan 16, 1990
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO214 citations99
US6348474B1Feb 19, 2002
Sulfonamide compounds and medicinal use thereof
FUJISAWA PHARMACEUTICAL CO124 citations97
US5308347AMay 3, 1994
Transfusion device
FUJISAWA PHARMACEUTICAL CO113 citations97
US4936841AJun 26, 1990
Fluid container
FUJISAWA PHARMACEUTICAL CO212 citations97
US4929611AMay 29, 1990
Method for immunosuppression
FUJISAWA PHARMACEUTICAL CO105 citations97
US4871549AOct 3, 1989
Time-controlled explosion systems and processes for preparing the same
FUJISAWA PHARMACEUTICAL CO334 citations97
US4409214AOct 11, 1983
7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
FUJISAWA PHARMACEUTICAL CO84 citations97
US6316482B1Nov 13, 2001
Benzamide derivatives having a vasopressin antagonistic activity
FUJISAWA PHARMACEUTICAL CO64 citations96
US6207693B1Mar 27, 2001
Benzamide derivatives having a vasopressin antagonistic activity
FUJISAWA PHARMACEUTICAL CO77 citations96
US5994368ANov 30, 1999
Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin antagonists
FUJISAWA PHARMACEUTICAL CO64 citations96
US5767293AJun 16, 1998
Oxaspiro 2,5! octane derivative
FUJISAWA PHARMACEUTICAL CO82 citations96
US5763437AJun 9, 1998
Benzodiazepine derivatives
FUJISAWA PHARMACEUTICAL CO101 citations96
US5624842AApr 29, 1997
Strain of Streptomyces for the production of tricyclo compounds
FUJISAWA PHARMACEUTICAL CO35 citations96
US5601844AFeb 11, 1997
Sustained release medicinal preparation
FUJISAWA PHARMACEUTICAL CO111 citations96
US5563162AOct 8, 1996
Bradykinin antagonist quinolines
FUJISAWA PHARMACEUTICAL CO55 citations96
US5550147AAug 27, 1996
Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
FUJISAWA PHARMACEUTICAL CO42 citations96
US5521170AMay 28, 1996
Benzamide derivatives and pharmaceutical composition comprising the same
FUJISAWA PHARMACEUTICAL CO70 citations96
US5496727AMar 5, 1996
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO22 citations96
US5356897AOct 18, 1994
3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
FUJISAWA PHARMACEUTICAL CO49 citations96
US5296490AMar 22, 1994
Pharmaceutically useful pyrazolopyridines
FUJISAWA PHARMACEUTICAL CO65 citations96
US5244890ASep 14, 1993
Cephem compounds
FUJISAWA PHARMACEUTICAL CO37 citations96
US5155114AOct 13, 1992
Method of treatment using pyrazolopyridine compound
FUJISAWA PHARMACEUTICAL CO61 citations96
US4985444AJan 15, 1991
Pyrazolopyridine compound and processes for preparation thereof
FUJISAWA PHARMACEUTICAL CO72 citations96
US4956352ASep 11, 1990
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO48 citations96
US4940709AJul 10, 1990
Piperazine compound as PAF-antagonist
FUJISAWA PHARMACEUTICAL CO67 citations96
US4925849AMay 15, 1990
Pharmaceutically useful pyrazolopyridines
FUJISAWA PHARMACEUTICAL CO45 citations96
US4822805AApr 18, 1989
Pyridyl-imidazole compounds which have useful pharmaceutical activity
FUJISAWA PHARMACEUTICAL CO88 citations96
US4806538AFeb 21, 1989
Piperazine compound as PAF-antagonist
FUJISAWA PHARMACEUTICAL CO52 citations96
US4797399AJan 10, 1989
Piperazine compounds and antithrombotic pharmaceutical composition comprising the same
FUJISAWA PHARMACEUTICAL CO59 citations96
US4743449AMay 10, 1988
Drug-containing lipid vesicle preparation and method for preparing them
FUJISAWA PHARMACEUTICAL CO143 citations96
US4734419AMar 29, 1988
Quinazoline derivatives, compositions thereof and their use in treating diabetic complications
FUJISAWA PHARMACEUTICAL CO66 citations96
US4725600AFeb 16, 1988
Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
FUJISAWA PHARMACEUTICAL CO62 citations96
US4649146AMar 10, 1987
Thiazole derivatives and pharmaceutical composition comprising the same
FUJISAWA PHARMACEUTICAL CO54 citations96
US4576753AMar 18, 1986
Azetidinone compounds and processes for preparation thereof
FUJISAWA PHARMACEUTICAL CO73 citations96
US4559334ADec 17, 1985
7-Substituted-3-vinyl-3-cephem compounds and processes for production of the same
FUJISAWA PHARMACEUTICAL CO89 citations96
US4487767ADec 11, 1984
7-[Amino or carboxy substituted oxyimino]-3-[amino or alkoxy substituted heterocyclic thiomethyl] cephalosporin derivatives
FUJISAWA PHARMACEUTICAL CO39 citations96
US4462999AJul 31, 1984
7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
FUJISAWA PHARMACEUTICAL CO30 citations96
US4423213ADec 27, 1983
7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
FUJISAWA PHARMACEUTICAL CO33 citations96
US4409215AOct 11, 1983
7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
FUJISAWA PHARMACEUTICAL CO35 citations96
US4366153ADec 28, 1982
Cephem compounds
FUJISAWA PHARMACEUTICAL CO43 citations96
US4341775AJul 27, 1982
Cephem compounds
FUJISAWA PHARMACEUTICAL CO37 citations96
US4338322AJul 6, 1982
1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
FUJISAWA PHARMACEUTICAL CO54 citations96
US4166115AAug 28, 1979
Syn 7-oxoimino substituted derivatives of cephalosporanic acid
FUJISAWA PHARMACEUTICAL CO69 citations96
US6884433B2Apr 26, 2005
Sustained release formulation containing tacrolimus
FUJISAWA PHARMACEUTICAL CO47 citations95
US6576259B2Jun 10, 2003
Sustained release formulations containing tacrolimus
FUJISAWA PHARMACEUTICAL CO57 citations95
US6440458B1Aug 27, 2002
Sustained release preparations
FUJISAWA PHARMACEUTICAL CO70 citations95
US6437146B1Aug 20, 2002
Oxazole compounds as prostaglandin e2 agonists or antagonists
FUJISAWA PHARMACEUTICAL CO112 citations95
Showing the top 50 of 925 patents by PatentIndex Score.